Pre-earnings options volume in Iovance Biotherapeutics (IOVA) is 2.5x normal with puts leading calls 9:4. Implied volatility suggests the market is anticipating a move near 14.2%, or 46c, after results are released. Median move over the past eight quarters is 11.1%.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IOVA: